Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.88)
# 1,643
Out of 5,111 analysts
5
Total ratings
60%
Success rate
59.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.46 | +764.86% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $2.13 | +134.74% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $17.70 | +35.59% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $1.83 | +227.87% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $4.63 | +180.78% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.46
Upside: +764.86%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $2.13
Upside: +134.74%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $17.70
Upside: +35.59%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.83
Upside: +227.87%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $4.63
Upside: +180.78%